CD192 / ATTO 488 / MLN1202 (Plozalizumab, hu1D9)
CD192 / ATTO 488 / MLN1202 (Plozalizumab, hu1D9)
Product Details
| Supplier | Absolute Antibody | |
|---|---|---|
| Catalog #: | Ab04182-3.3-atto488 (View supplier product page) | |
| Size | 100 μg | |
| Price | ||
| Antigen | CD192 | |
| Clone | MLN1202 (Plozalizumab, hu1D9) | |
| Host | Mouse | |
| Isotype | IgG2b | |
| Conjugate | ATTO 488 | |
| Target Species | Human | |
| Applications | Block/Neutralize, FC | |
| Description | Anti-CCR2 [MLN1202 (Plozalizumab, hu1D9)] |
About CD192 and ATTO 488
| CD192 | The protein encoded by this gene is a receptor for monocyte chemoattractant protein-1, a chemokine which specifically mediates monocyte chemotaxis. Monocyte chemoattractant protein-1 is involved in monocyte infiltration in inflammatory diseases such as rheumatoid arthritis as well as in the inflammatory response against tumors. The encoded protein mediates agonist-dependent calcium mobilization and inhibition of adenylyl cyclase. This protein can also be a coreceptor with CD4 for HIV-1 infection. This gene is located in the chemokine receptor gene cluster region of chromosome 3. [provided by RefSeq, Aug 2017] | |
|---|---|---|
| ATTO 488 | ATTO 488 is from ATTO-Tec Gmbh has an excitation peak at 501 nm and an emission peak at 523 nm. |
Citations
| Additional Sources |
|
|---|
